Navigation Links
Neurognostics pushes early prediction of brain disease

Milwaukee Score one for early prediction: Neurognostics, a firm in Milwaukee that develops devices for magnetic resonance imaging (MRI), has made strides since its founding two years ago toward the treatment of disorders before any physical signs develop.

"MRI is the most popular and useful mapping technique in the world ... in research," said Steve Rao, founder and chief science ......

Full article >>> no to study their drug Aricept, using MRI to analyze how effective it was in treating patients with multiple sclerosis. Tucker said Neurognostics is in the middle of negotiations with two other firms for similar projects.

"We assist the pharmaceutical company in making go or no go solutions, and we can do this by showing it's more sensitive then paper-pencil tests," Rao said.

......

Full article >>> mpany is trying to find new sites that have limited experience with functional MRI so they can learn how it operates in a neutral environment.

"We're hitting the pavement finding implementation sites," Tucker said.

Tucker said the company also plans to build off a Phase I Small Business Innovation Research grant the company received in October from the National Institutes of Heal......

Full article >>>
'"/>

Source:wistechnology.com By Les Chappell 03/16/05


Related biology technology :

1. Neurognostics to partner with Racine distributor
2. Neurognostics partners with Medical Numerics
3. Neurognostics recognized for MRI award
4. Neurognostics receives special FDA clearance for MindState fDAD
5. Neurognostics receives award for MRI innovation
6. Silva-Craig joins Neurognostics board
7. Wisconsin pushes for adoption of electronic health records
8. Biotech Alliance pushes ahead in SE Wisconsin with likely state funding
9. Rapid hit confirmation and early hERG liability testing using the IonWorks HT system
10. Venture Investors early-stage fund grows to $115 million
11. GE acquisition may boost "early" healthcare strategy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
(Date:6/22/2016)... June 22, 2016 Cell Applications, Inc. ... them to produce up to one billion human ... within one week. These high-quality, consistent stem cells ... cells and spend more time doing meaningful, relevant ... proprietary, high-volume manufacturing process that produces affordable, reliable ...
(Date:6/22/2016)... , June 22, 2016   ViaCyte, Inc. , ... stem cell-derived islet replacement therapy for the treatment of ... ISSCR 2016 Annual Meeting.  ISSCR 2016, the Global Stem ... at Moscone West in San Francisco.  ... presentations are as follows:Event: , Focus Session: Tools for ...
Breaking Biology Technology:
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
Breaking Biology News(10 mins):